MAPT and Parkinson disease: Our results have identified for the first time the state of Tau hyperphosphorylation in PD and DLB, which may be useful in not only understanding the genesis of these diseases at the molecular level, but also for the development of specific p-Tau and Tau kinase biomarkers.